Squarepoint’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.31M | Sell |
71,698
-213,665
| -75% | -$3.89M | ﹤0.01% | 1382 |
|
|
2025
Q1 | $5.66M | Sell |
285,363
-2,501
| -0.9% | -$49.6K | 0.01% | 720 |
|
|
2024
Q4 | $4.94M | Sell |
287,864
-67,424
| -19% | -$1.16M | ﹤0.01% | 775 |
|
|
2024
Q3 | $7.1M | Buy |
355,288
+2,092
| +0.6% | +$41.8K | 0.01% | 606 |
|
|
2024
Q2 | $3.95M | Buy |
353,196
+138,970
| +65% | +$1.55M | 0.01% | 766 |
|
|
2024
Q1 | $1.41M | Sell |
214,226
-48,992
| -19% | -$323K | ﹤0.01% | 1183 |
|
|
2023
Q4 | $1.19M | Buy |
263,218
+116,890
| +80% | +$528K | ﹤0.01% | 1276 |
|
|
2023
Q3 | $524K | Buy |
146,328
+104,078
| +246% | +$373K | ﹤0.01% | 1614 |
|
|
2023
Q2 | $156K | Buy |
+42,250
| New | +$156K | ﹤0.01% | 2137 |
|
|
2023
Q1 | – | Sell |
-29,334
| Closed | -$114K | – | 2220 |
|
|
2022
Q4 | $114K | Buy |
+29,334
| New | +$114K | ﹤0.01% | 2038 |
|
|
2022
Q2 | – | Sell |
-179,996
| Closed | -$329K | – | 2077 |
|
|
2022
Q1 | $329K | Buy |
179,996
+146,361
| +435% | +$268K | ﹤0.01% | 1685 |
|
|
2021
Q4 | $47K | Sell |
33,635
-58,291
| -63% | -$81.5K | ﹤0.01% | 2417 |
|
|
2021
Q3 | $104K | Sell |
91,926
-201,933
| -69% | -$228K | ﹤0.01% | 1992 |
|
|
2021
Q2 | $470K | Sell |
293,859
-281,466
| -49% | -$450K | ﹤0.01% | 1651 |
|
|
2021
Q1 | $1.01M | Buy |
575,325
+453,024
| +370% | +$798K | 0.01% | 1057 |
|
|
2020
Q4 | $238K | Buy |
122,301
+104,595
| +591% | +$204K | ﹤0.01% | 2025 |
|
|
2020
Q3 | $42K | Sell |
17,706
-61,738
| -78% | -$146K | ﹤0.01% | 2222 |
|
|
2020
Q2 | $233K | Buy |
79,444
+60,462
| +319% | +$177K | ﹤0.01% | 1694 |
|
|
2020
Q1 | $55K | Sell |
18,982
-13,577
| -42% | -$39.3K | ﹤0.01% | 1704 |
|
|
2019
Q4 | $130K | Buy |
+32,559
| New | +$130K | ﹤0.01% | 2212 |
|
|
2018
Q4 | – | Sell |
-11,600
| Closed | -$72K | – | 1885 |
|
|
2018
Q3 | $72K | Buy |
11,600
+554
| +5% | +$3.44K | ﹤0.01% | 1899 |
|
|
2018
Q2 | $50K | Buy |
+11,046
| New | +$50K | ﹤0.01% | 1690 |
|